Trials / Terminated
TerminatedNCT05205447
Study of the Effects of Itraconazole and Carbamazepine on LY3410738 in Healthy Participants
A Phase 1, Two-part, Open-label, Fixed-sequence Study to Evaluate the Effects of Multiple Doses of Itraconazole and Carbamazepine on the Single-dose Pharmacokinetics of LY3410738 in Healthy Adult Subjects
- Status
- Terminated
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 27 (actual)
- Sponsor
- Eli Lilly and Company · Industry
- Sex
- All
- Age
- 18 Years – 55 Years
- Healthy volunteers
- Accepted
Summary
The main purpose of this study is to learn about how itraconazole and carbamazepine affect the levels of LY3410738 in the blood stream of healthy participants. Participation could last up to 75 days.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | LY3410738 | Oral LY3410738 |
| DRUG | Itraconazole | Oral Itraconazole |
| DRUG | Carbamazepine | Oral Carbamazepine |
Timeline
- Start date
- 2022-01-05
- Primary completion
- 2022-04-12
- Completion
- 2022-04-12
- First posted
- 2022-01-25
- Last updated
- 2022-12-28
Locations
1 site across 1 country: United States
Regulatory
- FDA-regulated drug study
Source: ClinicalTrials.gov record NCT05205447. Inclusion in this directory is not an endorsement.